Why is SARS-CoV-2 infection milder among children?

Clinics (Sao Paulo). 2020:75:e1947. doi: 10.6061/clinics/2020/e1947. Epub 2020 May 15.

Authors

Patricia Palmeira¹, José Alexandre M Barbuto², Clovis Artur A Silva³, Magda Carneiro-Sampaio¹

Affiliations

¹ Laboratorio de Investigacao Medica (LIM-36), Departamento de Pediatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.
² Departamento Imunologia, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP, BR.
³ Departamento de Pediatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR.

No abstract available

Publication types

Editorial

MeSH terms

Angiotensin-Converting Enzyme 2
Asymptomatic Diseases
Betacoronavirus / pathogenicity*
COVID-19
Child
Coronavirus Infections / immunology
Coronavirus Infections / metabolism*
Coronavirus Infections / physiopathology
Humans
Immunity, Innate
Pandemics
Peptidyl-Dipeptidase A / metabolism*
Pneumonia, Viral / immunology
Pneumonia, Viral / metabolism*
Pneumonia, Viral / physiopathology
SARS-CoV-2
Severity of Illness Index

Substances

Peptidyl-Dipeptidase A
ACE2 protein, human
Angiotensin-Converting Enzyme 2